Log In
Print this Print this

biosimilar etanercept (Etacept)

  Manage Alerts
Collapse Summary General Information
Company 3SBio Inc.
DescriptionBiosimilar version of etanercept, a recombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha ; Lymphotoxin alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Biosimilar
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentMarketed
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat rheumatic disorders
Regulatory Designation
PartnerCipla Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today